









Besser lernen dank der zahlreichen Ressourcen auf Docsity
Heimse Punkte ein, indem du anderen Studierenden hilfst oder erwirb Punkte mit einem Premium-Abo
Prüfungen vorbereiten
Besser lernen dank der zahlreichen Ressourcen auf Docsity
Download-Punkte bekommen.
Heimse Punkte ein, indem du anderen Studierenden hilfst oder erwirb Punkte mit einem Premium-Abo
Acid-Base Regulation and Disorders
Art: Leitfäden, Projektarbeiten und Recherchen
1 / 16
Diese Seite wird in der Vorschau nicht angezeigt
Lass dir nichts Wichtiges entgehen!










Understanding acid‑base regulation is fundamental to clinical medicine because even small deviations from normal pH can have profound effects on organ function. This resource provides a comprehensive, evidence‑based, exam‑ready framework for the evaluation and management of acid‑base disorders, integrating the most current 2025‑2026 guidelines.
The body maintains arterial pH within a narrow range of 7.35–7.45 through the coordinated action of chemical buffers, the lungs, and the kidneys. Disorders arise when the primary disturbance is respiratory (altering Pco₂) or metabolic (altering HCO₃⁻), with the opposing system providing compensation.
The relationship between pH, bicarbonate, and carbon dioxide is defined by the Henderson‑Hasselbalch equation, the cornerstone of acid‑base physiology: pH = 6.1 + log (HCO₃⁻ / 0.03 × Pco₂) This equation shows that pH is determined by the ratio of HCO₃⁻ (controlled by the kidneys) to Pco₂ (controlled by the lungs). The normal ratio is 20:1 (i.e., 24 mEq/L HCO₃⁻ / 1.2 mmHg Pco₂), which yields a normal pH of 7.40.
The bicarbonate buffer system is the most important extracellular buffer, while intracellular buffers include proteins, phosphates, and hemoglobin. The Henderson‑Hasselbalch equation shows why this system is so efficient: the open system allows the lungs to regulate CO₂ elimination, which rapidly adjusts the ratio and therefore the pH. Hemoglobin also plays a critical role; deoxygenated hemoglobin binds more H⁺ than oxygenated hemoglobin, a key mechanism for CO₂ transport and buffering in the tissues. This is the Haldane effect, which facilitates the exchange of oxygen and carbon dioxide in the periphery and the lungs.
Unlike chemical buffers, which act instantly, and respiratory compensation, which occurs within minutes, the kidney’s adjustments develop over hours to days.
Step 1: Obtain ABG and serum electrolytes (including albumin) ↓ Step 2: Evaluate pH and Pco₂ – is the primary disorder respiratory or metabolic? ↓ Step 3: Assess the degree of compensation using expected formulas ↓ Step 4: If pH is abnormal but compensation is appropriate → simple disorder. If compensation is inappropriate → mixed disorder. ↓ Step 5: Calculate the anion gap (AG = Na⁺ − [Cl⁻ + HCO₃⁻]). ↓ Step 6: If AG is elevated, calculate the delta gap (ΔAG – ΔHCO₃⁻) or delta ratio. ↓ Step 7: In metabolic acidosis, identify the specific cause using the history, lactate, osmolal gap, ketones, and toxicology screen.
### 2.1 Anion Gap (AG) The anion gap is the difference between unmeasured anions and cations and is a critical tool for narrowing the differential diagnosis of metabolic acidosis. The normal AG is **8‑12 mEq/L** when measured by standard methods, but this range is albumin‑dependent. **Anion gap formula**: AG = Na⁺ – (Cl⁻ + HCO₃⁻) **Albumin correction**: For every 1 g/dL drop in serum albumin below 4 g/dL, the normal AG falls by approximately 2.5 mEq/L. A corrected AG should be calculated in hypoalbuminaemic patients to avoid missing a high AG acidosis. ### 2.2 The Delta Gap and Delta Ratio In a patient with a **high anion gap metabolic acidosis (HAGMA)** , the fall in HCO₃⁻ should theoretically equal the rise in the AG (a 1:1 relationship). The delta ratio quantifies this relationship and identifies coexisting metabolic disorders. **Delta ratio formula**: Delta ratio = (Actual AG – Normal AG) / (Normal HCO₃⁻ – Measured HCO₃⁻) | **Delta Ratio** | **Interpretation** | | :--- | :--- | | <0.4 | Pure non‑AG metabolic acidosis (may occur if AG is normal but HCO₃⁻ is low) | | 0.4 – 0.8 | Mixed high AG and non‑AG metabolic acidosis | | 0.8 – 1.2 (or 1‑2) | Pure high AG metabolic acidosis (e.g., DKA, lactic acidosis) | | 1.2 – 2.0 | Mixed high AG metabolic acidosis and metabolic alkalosis | | >2.0 | Metabolic alkalosis (with compensatory HCO₃⁻ elevation) | ### 2.3 Winter‘s Formula Winter’s formula is used to evaluate the appropriateness of respiratory compensation for a metabolic acidosis and to detect mixed disorders. **Expected Pco₂ = 1.5 × HCO₃⁻ + 8 ± 2** - If the measured Pco₂ is **higher** than predicted → a **concurrent respiratory acidosis** is present. - If the measured Pco₂ is **lower** than predicted → a **concurrent respiratory alkalosis** is present. ### 2.4 Urine Anion Gap (UAG) and Urine Osmolal Gap (UOG) In patients with a **non‑anion gap metabolic acidosis (NAGMA)** , the urinary findings help differentiate renal from extrarenal causes. | ↓ Renin, ↓ Aldosterone | Hyporeninemic hypoaldosteronism (most common in diabetic nephropathy, CKD) | Fludrocortisone, loop diuretics, dietary K⁺ restriction | | ↑ Renin, ↓ Aldosterone | Primary adrenal insufficiency (Addison‘s disease, congenital enzyme defects) | Mineralocorticoid and glucocorticoid replacement | | ↑ Renin, ↑ Aldosterone | Pseudohypoaldosteronism (aldosterone resistance; rare; PHA1) | Thiazides, Na⁺ supplementation | ### 3.3 Parathyroid Hormone (PTH) In patients with advanced CKD, secondary hyperparathyroidism (SHPT) is associated with a worsening metabolic acidosis, primarily due to impaired ammonium excretion. Treatment of SHPT with vitamin D analogues or calcimimetics may improve acid‑base status. --- ## 🏥 Part 4 : Clinical Case Studies ### Case Study 1: A 24‑Year‑Old Woman with Polyuria, Polydipsia, and Nausea – Diabetic Ketoacidosis (DKA) **History**: A 24‑year‑old woman with type 1 diabetes presents with 2 days of polyuria, polydipsia, nausea, and vomiting. She reports she has not taken her insulin for the past 24 hours. On examination, she is tachypnoeic (respiratory rate 28/min) with a fruity odour on her breath. **Workup**: - **ABG**: pH 7.21, Pco₂ 28 mmHg, HCO₃⁻ 10 mEq/L. - **Electrolytes**: Na⁺ 135 mEq/L, K⁺ 5.2 mEq/L, Cl⁻ 98 mEq/L. - **Glucose**: 650 mg/dL. - **Beta‑hydroxybutyrate**: markedly elevated. **Analysis**: 1. **Primary disorder**: pH < 7.35 → metabolic acidosis. 2. **Winter’s formula**: Expected Pco₂ = 1.5 × 10 + 8 ± 2 = 23 ± 2 mmHg. Measured Pco₂ (28 mmHg) is within 5 mmHg of predicted → **pure metabolic acidosis** (no respiratory component). 3. **Anion gap**: AG = 135 – (98 + 10) = 27 (elevated, normal ≈12). 4. **Delta ratio**: (27‑12) / (24‑10) = 15 / 14 = 1.07 → **pure HAGMA**, consistent with DKA. **Diagnosis**: Diabetic ketoacidosis (DKA). **Management**: - The 2024 ADA consensus report simplifies management to three main areas: **fluids, insulin, and potassium**; routine bicarbonate and phosphate administration is not recommended. - Bicarbonate should be considered only in severe acidosis (pH < 7.0). - Resolution of DKA is defined as venous pH ≥7.3 (or HCO₃⁻ ≥18 mEq/L), glucose <200 mg/dL, and anion gap ≤12 mEq/L. --- ### Case Study 2: A 68‑Year‑Old Man with Severe Diarrhoea – Hyperchloraemic Metabolic Acidosis **History**: An 68‑year‑man with a 3‑day history of profuse watery diarrhoea. He is now weak and light‑headed. He takes no medications. **Workup**: - **ABG**: pH 7.29, Pco₂ 30 mmHg, HCO₃⁻ 14 mEq/L. - **Electrolytes**: Na⁺ 138 mEq/L, K⁺ 3.2 mEq/L, Cl⁻ 112 mEq/L. - **Albumin**: 3.2 g/dL. **Analysis**: 1. **Primary disorder**: pH < 7.35 → metabolic acidosis. **Diagnosis**: Mixed high‑anion gap metabolic acidosis (from DKA) and metabolic alkalosis (from vomiting). The delta ratio of 1.5 indicates a coexisting alkalotic process, and the higher than expected Pco₂ supports a combined respiratory acidosis or a primary metabolic alkalosis with compensatory hypoventilation. **Management**: Treat the underlying DKA with insulin and fluids; the metabolic alkalosis will typically resolve as the vomiting ceases. --- ### Case Study 4: Type 4 Renal Tubular Acidosis in a Patient with Diabetic Nephropathy **History**: A 65‑year‑old man with long‑standing diabetes and chronic kidney disease (eGFR 35 mL/min/1.73 m²) presents with slowly progressive fatigue. His medications include metformin and losartan. Laboratory evaluation reveals a serum creatinine of 2.2 mg/dL and a glucose of 110 mg/dL. **Workup**: - **ABG**: pH 7.32, Pco₂ 30 mmHg, HCO₃⁻ 15 mEq/L. - **Electrolytes**: Na⁺ 140 mEq/L, K⁺ 5.6 mEq/L, Cl⁻ 110 mEq/L. - **Anion gap**: AG = 140 – (110 + 15) = 15 (normal after accounting for low albumin, approx. 10‑12). Therefore, this is a **non‑AG metabolic acidosis**. - **Urine anion gap**: Urine Na⁺ 50 mEq/L, K⁺ 30 mEq/L, Cl⁻ 65 mEq/L → UAG = (50 + 30) – 65 = + (positive). - **Aldosterone**: low, renin: low. **Diagnosis**: Type 4 RTA (hyporeninemic hypoaldosteronism) secondary to diabetic nephropathy. The acidosis is hyperkalaemic and characterised by a positive urine anion gap due to impaired ammonium excretion. **Management**: Dietary potassium restriction; fludrocortisone 0.1 mg/day (if hyperkalaemia is severe), but it may worsen oedema; loop diuretics (furosemide) to lower serum K⁺ by increasing distal Na⁺ delivery. ### Case Study 5: Severe Lactic Acidosis Type A – Sepsis with Multiorgan Failure **History**: A 70‑year‑old man with septic shock secondary to urosepsis. He is hypotensive (MAP 50 mmHg) on norepinephrine and has cool, mottled extremities. **Workup**: - **ABG**: pH 7.10, Pco₂ 23 mmHg, HCO₃⁻ 7 mEq/L. - **Electrolytes**: Na⁺ 142 mEq/L, K⁺ 4.0 mEq/L, Cl⁻ 100 mEq/L. - **Lactate**: 12 mmol/L. **Analysis**: 1. **Primary disorder**: pH < 7.35 → metabolic acidosis. 2. **Anion gap**: AG = 142 – (100 + 7) = 35 (markedly elevated). 3. **Delta ratio**: (35‑12) / (24‑7) = 23 / 17 = 1.35 → **pure HAGMA**. 4. **Cause**: The high lactate level and clinical picture of hypoperfusion confirm **type A lactic acidosis**. **Diagnosis**: Type A lactic acidosis (due to global tissue hypoxia from septic shock). **Management**: Treat the underlying cause (source control, antibiotics); restore tissue perfusion with fluids and vasopressors; treat acidosis only if pH < 7.15‑7.20 with careful administration of intravenous bicarbonate; avoid indiscriminate bicarbonate use (it may worsen intracellular acidosis). --- ## 📝 Part 5 : Exam‑Style Questions & Answers **Q3:** A 32‑year‑old patient with a 3‑day history of severe diarrhoea has the following ABG: pH 7.30, Pco₂ 35 mmHg, HCO₃⁻ 17 mEq/L. Electrolytes: Na⁺ 135 mEq/L, K⁺ 3.0 mEq/L, Cl⁻ 110 mEq/L. A spot urine sample is obtained, and the urine electrolytes are Na⁺ 40 mEq/L, K⁺ 25 mEq/L, Cl⁻ 80 mEq/L. What is the most appropriate interpretation of the urine anion gap? A) UAG is positive (+15) → renal tubular acidosis B) UAG is negative (−15) → extrarenal (GI) cause C) UAG is positive (+5) → normal D) UAG is negative (−5) → lithium therapy > **Answer: B** > **Explanation:** The urine anion gap = Na⁺ + K⁺ − Cl⁻ = (40 + 25) − 80 = −15 mEq/L. A negative UAG indicates appropriate renal ammonium excretion, pointing to an extrarenal (gastrointestinal) cause of the non‑AG metabolic acidosis, such as diarrhoea. **Q4:** A patient with septic shock is found to have an arterial blood gas: pH 7.15, Pco₂ 30 mmHg, HCO₃⁻ 10 mEq/L. Calculated anion gap is 28, and the delta ratio is 1.2. Which of the following is the most accurate conclusion? A) A mixed metabolic alkalosis is present B) This is a pure high‑anion gap metabolic acidosis C) A mixed respiratory acidosis is present D) A mixed non‑anion gap acidosis is present > **Answer: B** > **Explanation:** The delta ratio (ΔAG / ΔHCO₃⁻) is approximately 1.2, which falls within the range (0.8‑1.2) typically seen in a pure high‑anion gap metabolic acidosis. This excludes a significant coexisting metabolic alkalosis (which would have a delta ratio >2) or a pure non‑anion gap acidosis (which would have a normal AG). **Q5:** A 68‑year‑old man with type 2 diabetes and CKD stage 4 presents with fatigue. ABG shows pH 7.31, Pco₂ 34 mmHg, HCO₃⁻ 16 mEq/L. AG is 16 after correction. His urine anion gap is positive. Which type of renal tubular acidosis is most consistent with these findings? A) Type 1 (distal) RTA B) Type 2 (proximal) RTA C) Type 4 (hyperkalaemic) RTA D) Type 3 (mixed) RTA > **Answer: C** > **Explanation:** Type 4 RTA is the most common RTA seen in clinical practice. It is associated with hypoaldosteronism (often related to diabetic nephropathy) and presents with hyperkalaemia and a positive urine anion gap. This contrasts with types 1 and 2 RTA, which typically present with hypokalaemia. ### Short Answer Questions 1. **Q: What are the three independent determinants of acid‑base balance according to the Stewart approach, and what does the strong ion gap (SIG) represent?** A: The three independent determinants are the strong ion difference (SID = total strong cations – total strong anions), the partial pressure of carbon dioxide (Pco₂), and the total concentration of non‑volatile weak acids (Atot, primarily albumin and phosphate). The strong ion gap (SIG) represents the concentration of unmeasured strong ions and is analogous to the traditional anion gap, but corrected for albumin and phosphate. 2. **Q: A patient has a normal anion gap metabolic acidosis (NAGMA). How can the urine anion gap (UAG) be used to distinguish a GI from a renal cause?** A: In a GI cause (e.g., diarrhoea), the kidneys are able to excrete ammonium normally, resulting in a **negative** UAG. In a renal cause (e.g., renal tubular acidosis), ammonium excretion is impaired, resulting in a **positive** UAG. 3. **Q: A 45‑year‑old patient with a normal anion gap metabolic acidosis, hypokalaemia, and a urine pH of 6.5 during systemic acidosis. What is the most likely diagnosis?** A: Distal (type 1) renal tubular acidosis (RTA). Inability to lower urine pH below 5.5 in the setting of systemic acidosis is the hallmark of distal RTA. This is often associated with hypokalaemia due to impaired acid secretion and secondary aldosterone activation. ## 📚 Key References 1. Merck Manual Professional Edition. **Acid‑Base Disorders**. 2025. 2. AMBOSS. **Acid‑Base Disorders**. 2025. 3. StatPearls. **Lactic Acidosis**. 2025. 4. Role of the Endocrine System in Acid‑Base Balance. *PMC*. 2024. 5. Renal Tubular Acidosis – Merck Manual Professional Edition. 2026. 6. Management of Diabetic Ketoacidosis. *BMJ Best Practice*. 2025. 7. Stewart Approach to Acid‑Base. *Broome Docs*. 8. Approach to Acid‑Base Disorders – AAFP. 2025. --- *This resource is intended for educational and examination preparation purposes. Always correlate with local institutional guidelines and consult a specialist for complex cases.*